Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 37

1.

Diabetes mellitus and the risk of gastric cancer: a meta-analysis of cohort studies.

Miao ZF, Xu H, Xu YY, Wang ZN, Zhao TT, Song YX, Xu HM.

Oncotarget. 2017 Jul 4;8(27):44881-44892. doi: 10.18632/oncotarget.16487. Review.

2.

Metabolic syndrome and total cancer mortality in the Third National Health and Nutrition Examination Survey.

Gathirua-Mwangi WG, Monahan PO, Murage MJ, Zhang J.

Cancer Causes Control. 2017 Feb;28(2):127-136. doi: 10.1007/s10552-016-0843-1. Epub 2017 Jan 17.

PMID:
28097473
3.

Diabetes, plasma glucose and incidence of pancreatic cancer: A prospective study of 0.5 million Chinese adults and a meta-analysis of 22 cohort studies.

Pang Y, Kartsonaki C, Guo Y, Bragg F, Yang L, Bian Z, Chen Y, Iona A, Millwood IY, Lv J, Yu C, Chen J, Li L, Holmes MV, Chen Z.

Int J Cancer. 2017 Apr 15;140(8):1781-1788. doi: 10.1002/ijc.30599. Epub 2017 Feb 8.

4.

Diabetes mellitus and metformin in hepatocellular carcinoma.

Fujita K, Iwama H, Miyoshi H, Tani J, Oura K, Tadokoro T, Sakamoto T, Nomura T, Morishita A, Yoneyama H, Masaki T.

World J Gastroenterol. 2016 Jul 21;22(27):6100-13. doi: 10.3748/wjg.v22.i27.6100. Review.

5.

Blood glucose concentration and risk of pancreatic cancer: systematic review and dose-response meta-analysis.

Liao WC, Tu YK, Wu MS, Lin JT, Wang HP, Chien KL.

BMJ. 2015 Jan 2;350:g7371. doi: 10.1136/bmj.g7371. Review. Erratum in: BMJ. 2016 Jul 22;354:i4089.

6.

Independent and joint effect of type 2 diabetes and gastric and hepatobiliary diseases on risk of pancreatic cancer risk: 10-year follow-up of population-based cohort.

Lin CC, Chiang JH, Li CI, Hsieh TF, Liu CS, Lin WY, Lee YD, Li TC.

Br J Cancer. 2014 Nov 25;111(11):2180-6. doi: 10.1038/bjc.2014.525. Epub 2014 Oct 2.

7.

Cancer risks among patients with type 2 diabetes: a 10-year follow-up study of a nationwide population-based cohort in Taiwan.

Lin CC, Chiang JH, Li CI, Liu CS, Lin WY, Hsieh TF, Li TC.

BMC Cancer. 2014 May 29;14:381. doi: 10.1186/1471-2407-14-381.

8.

Plasma levels of glucose and insulin in patients with brain tumors.

Alexandru O, Ene L, Purcaru OS, Tache DE, Popescu A, Neamtu OM, Tataranu LG, Georgescu AM, Tudorica V, Zaharia C, Dricu A.

Curr Health Sci J. 2014 Jan;40(1):27-36. doi: 10.12865/CHSJ.40.01.05. Epub 2013 Dec 29.

9.

Plasma glucose regulation and mortality in Korea: a pooled analysis of three community-based cohort studies.

Kim NH, Kim DJ, Park SW, Oh JY, Park JY, Shin C, Lee HK, Park Y; Committee on the Epidemiology of Diabetes Mellitus, Korean Diabetes Association.

Diabetes Metab J. 2014 Feb;38(1):44-50. doi: 10.4093/dmj.2014.38.1.44. Epub 2014 Feb 19.

10.

Fatty acids found in dairy, protein and unsaturated fatty acids are associated with risk of pancreatic cancer in a case-control study.

Jansen RJ, Robinson DP, Frank RD, Anderson KE, Bamlet WR, Oberg AL, Rabe KG, Olson JE, Sinha R, Petersen GM, Stolzenberg-Solomon RZ.

Int J Cancer. 2014 Apr 15;134(8):1935-46. doi: 10.1002/ijc.28525. Epub 2013 Oct 29.

11.

Pre-existing diabetes mellitus increases the risk of gastric cancer: a meta-analysis.

Yoon JM, Son KY, Eom CS, Durrance D, Park SM.

World J Gastroenterol. 2013 Feb 14;19(6):936-45. doi: 10.3748/wjg.v19.i6.936. Review.

12.

Diabetes mellitus and risk of hepatocellular carcinoma: findings from the Singapore Chinese Health Study.

Koh WP, Wang R, Jin A, Yu MC, Yuan JM.

Br J Cancer. 2013 Mar 19;108(5):1182-8. doi: 10.1038/bjc.2013.25. Epub 2013 Jan 31.

13.

Soluble ST2 associates with diabetes but not established cardiovascular risk factors: a new inflammatory pathway of relevance to diabetes?

Miller AM, Purves D, McConnachie A, Asquith DL, Batty GD, Burns H, Cavanagh J, Ford I, McLean JS, Packard CJ, Shiels PG, Turner H, Velupillai YN, Deans KA, Welsh P, McInnes IB, Sattar N.

PLoS One. 2012;7(10):e47830. doi: 10.1371/journal.pone.0047830. Epub 2012 Oct 24.

14.

Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium.

Elena JW, Steplowski E, Yu K, Hartge P, Tobias GS, Brotzman MJ, Chanock SJ, Stolzenberg-Solomon RZ, Arslan AA, Bueno-de-Mesquita HB, Helzlsouer K, Jacobs EJ, LaCroix A, Petersen G, Zheng W, Albanes D, Allen NE, Amundadottir L, Bao Y, Boeing H, Boutron-Ruault MC, Buring JE, Gaziano JM, Giovannucci EL, Duell EJ, Hallmans G, Howard BV, Hunter DJ, Hutchinson A, Jacobs KB, Kooperberg C, Kraft P, Mendelsohn JB, Michaud DS, Palli D, Phillips LS, Overvad K, Patel AV, Sansbury L, Shu XO, Simon MS, Slimani N, Trichopoulos D, Visvanathan K, Virtamo J, Wolpin BM, Zeleniuch-Jacquotte A, Fuchs CS, Hoover RN, Gross M.

Cancer Causes Control. 2013 Jan;24(1):13-25. doi: 10.1007/s10552-012-0078-8. Epub 2012 Oct 31.

15.

The influence of type 2 diabetes and glucose-lowering therapies on cancer risk in the Taiwanese.

Hsieh MC, Lee TC, Cheng SM, Tu ST, Yen MH, Tseng CH.

Exp Diabetes Res. 2012;2012:413782. doi: 10.1155/2012/413782. Epub 2012 Jun 5.

16.

Concentrations of IGF-I and IGFBP-3 and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition.

Rohrmann S, Grote VA, Becker S, Rinaldi S, Tjønneland A, Roswall N, Grønbæk H, Overvad K, Boutron-Ruault MC, Clavel-Chapelon F, Racine A, Teucher B, Boeing H, Drogan D, Dilis V, Lagiou P, Trichopoulou A, Palli D, Tagliabue G, Tumino R, Vineis P, Mattiello A, Rodríguez L, Duell EJ, Molina-Montes E, Dorronsoro M, Huerta JM, Ardanaz E, Jeurnink S, Peeters PH, Lindkvist B, Johansen D, Sund M, Ye W, Khaw KT, Wareham NJ, Allen NE, Crowe FL, Fedirko V, Jenab M, Michaud DS, Norat T, Riboli E, Bueno-de-Mesquita HB, Kaaks R.

Br J Cancer. 2012 Feb 28;106(5):1004-10. doi: 10.1038/bjc.2012.19. Epub 2012 Feb 7.

17.

The role of pre-existing diabetes mellitus on hepatocellular carcinoma occurrence and prognosis: a meta-analysis of prospective cohort studies.

Yang WS, Va P, Bray F, Gao S, Gao J, Li HL, Xiang YB.

PLoS One. 2011;6(12):e27326. doi: 10.1371/journal.pone.0027326. Epub 2011 Dec 21.

18.

Diabetes mellitus and gastric carcinoma: Is there an association?

Marimuthu SP, Vijayaragavan P, Moysich KB, Jayaprakash V.

J Carcinog. 2011;10:30. doi: 10.4103/1477-3163.90481. Epub 2011 Dec 2.

19.

Diabetes and pancreatic cancer.

Li D.

Mol Carcinog. 2012 Jan;51(1):64-74. doi: 10.1002/mc.20771.

20.

Diabetes and risk of bladder cancer: evidence from a case-control study in New England.

MacKenzie T, Zens MS, Ferrara A, Schned A, Karagas MR.

Cancer. 2011 Apr 1;117(7):1552-6. doi: 10.1002/cncr.25641. Epub 2010 Nov 8.

Supplemental Content

Support Center